Clinical trial to test nipocalimab vs IVIG to prevent FNAIT
A new trial is testing whether nipocalimab can lower the risk of severe bleeding and death in babies at risk of FNAIT.
A new trial is testing whether nipocalimab can lower the risk of severe bleeding and death in babies at risk of FNAIT.
Stronger communication with staff can ease stress, improve trust and help parents feel more involved in their child’s care.
Of the staff surveyed, 92% said noise harms infants, while 76% linked it to errors in care caused by distracted or overwhelmed clinicians.
In mothers with FNAIT, antibodies attach much more strongly to platelet proteins than to proteins on blood vessel cells.
A specialized form of MRI can help explain why cerebrospinal fluid builds up in newborns with brain bleeds, such as those seen in FNAIT.
The FREESIA-1 trial is testing a drug that could stop fetal and neonatal alloimmune thrombocytopenia before it starts.
A new next-generation sequencing method allows advanced tracking of transfused platelets in FNAIT, regardless of ethnicity or multiple transfusions.
Comprehensive strategies linking obstetrics and neonatology reduced maternal separation anxiety in families affected by FNAIT.
Most UK fetal medicine centers agreed on using intravenous immunoglobulin to treat FNAIT, but opinions varied on when to begin treatment.
A study found brain injury and inflammation markers may not reliably reflect treatment progress for intraventricular hemorrhage (IVH).